Weaned pig responses to Escherichia coli K88 oral challenge when receiving a lysozyme supplement

• Published in: Journal of animal science Vol. 90; no. 1; pp. 252 - 260
• Main Authors: Nyachoti, C. M, Kiarie, E, Bhandari, S. K, Zhang, G, Krause, D. O
• Format: Journal Article
• Language: English
• Published: United States American Society of Animal Science 2012
• Subjects: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Anti-Bacterial Agents - administration & dosage; Anti-Bacterial Agents - pharmacology; antimicrobial properties; blood; chlortetracycline; diarrhea; diet; Dietary Supplements; digesta; Dose-Response Relationship, Drug; drinking water; enterotoxigenic Escherichia coli; Enterotoxigenic Escherichia coli - immunology; Enterotoxigenic Escherichia coli - isolation & purification; Escherichia coli; Escherichia coli Infections - blood; Escherichia coli Infections - drug therapy; Escherichia coli Infections - veterinary; growth performance; ileum; interleukin-6; Interleukin-6 - blood; intestinal mucosa; Intestine, Small - microbiology; Intestine, Small - physiology; lysozyme; Muramidase - administration & dosage; Muramidase - pharmacology; nutrients; piglets; Random Allocation; Swine; Swine Diseases - blood; Swine Diseases - drug therapy; swine feeding; Tumor Necrosis Factor-alpha - blood; villi; Water - chemistry; Weaning; British Columbia
• ISSN: 0021-8812; 1525-3163
• DOI: 10.2527/jas.2010-3596

Lysozyme is a low-molecular-weight protein with antimicrobial properties. An experiment was conducted to investigate the response of piglets receiving a water-soluble lysozyme supplement [Entegard (EG), Neova Technologies Inc., Abbotsford, British Columbia, Canada; 4,000 lysozyme units/mg] after oral challenge with enterotoxigenic Escherichia coli (ETEC). A total of 36 individually housed weanling pigs were randomly allotted to 1 of the 4 treatments, with 9 replicates per treatment. Treatments were a control (CONT, no additive), antibiotic (AB; 2.5 g/kg of feed of antibiotic with chlortetracycline, sulfamethazine, and penicillin), and EG delivered in the drinking water at concentrations of 0.1% (EG1) and 0.2% (EG2). All pigs received a basal diet similar in composition and nutrients, except for pigs receiving the AB diet, which had an added antibiotic. Pigs were acclimated to treatments for a 7-d period to monitor growth performance. On d 8, blood samples were collected from each pig to obtain serum, and each pig was gavaged with 6 mL (2 x 109 cfu/mL) of ETEC solution. Pigs were monitored for another 7 d to assess incidences of diarrhea and growth performance, and then all pigs were killed to obtain intestinal tissue and digesta samples. Treatments did not influence growth performance throughout the study. Greater ETEC counts were observed in the ileal mucosal scrapings (P = 0.001) and colonic digesta (P = 0.025) of pigs in the CONT group compared with pigs in the AB and EG1 groups. Pigs receiving AB and EG1 had greater (P < 0.05) small intestinal weights and ileal villus heights than pigs receiving CONT; however, the ileal villus height-to-crypt depth ratio was greater in pigs fed the AB diet (1.69) compared with those fed the CONT diet (1.34), whereas pigs receiving EG1 were intermediate. Pigs in the EG1 group showed greater (P < 0.001) serum tumor necrosis factor α and IL-6 concentrations before ETEC challenge; however, at 7 d postchallenge, pigs receiving EG2 showed the least (P < 0.05) circulating tumor necrosis factor α and IL-6 concentrations. Overall, better intestinal growth and development, as well as decreased ETEC counts on the intestinal mucosa and serum proinflammatory cytokines, suggest that EG can maintain gut health and function in piglets commensurate with antibiotics. However, it is noteworthy that at the largest dose tested, EG seemed to have a dramatic effect on proinflammatory cytokines but had a minimal or no effect on the other response criteria.